MarketInOut Stock Screener Log In | Sign Up

Moderna Inc

XETRA • Healthcare • Biotechnology • Quote as of 10/30/2026
Moderna Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeXETRA
Market Capitalization79,432 mln
Float365 mln
Earnings Date11/05/2026

Piotroski F-Score

1 / 9
Very weak

Beneish M-Score

-3.22
Reliable

Relative Strength

92 / 100
Top performer

Debt / Equity

0.19
Very low leverage

Pre-Tax Margin

-139%
Severely loss-making

ROE

-37.92
Deeply negative

Business Description

Moderna is a biotechnology company founded in 2010 and based in Cambridge, Massachusetts, that develops medicines using messenger RNA technology. Its product portfolio spans vaccines for respiratory illnesses, viral infections, and bacterial diseases, as well as treatments for certain cancers and rare genetic conditions. The company works alongside prominent partners including Merck, Vertex Pharmaceuticals, the Bill & Melinda Gates Foundation, and OpenAI to advance its research and bring new treatments to patients around the world.

Key Fundamentals

EPS-6.84
ROE-37.92
ROIC-49.23
ROA-26.73
EBITDA, mln-2,404
EV / EBITDA-28.21
EV / EBIT-25.98
Revenue, mln1,909
EV / Revenue35.51

Quote Details

Last 198.96
Change 3.9 (2%)
Open 197.34
Volume 14,441
Turnover 2,873,182
Average Volume 32,616

Financial Ratios

Pre-Tax Profit Margin-139
Current Ratio2.30
Price / Book12.27
Price / Tangible Book12.57
Debt / Equity0.19
Price / Sales36.59

Financial Strength

Altman Z-Score12.16
Piotroski F-Score 1 / 9
Beneish M-Score-3.22
Price to Intrinsic Value4.40
Shiller PE Ratio192

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 10.17% 99 / 100   
1 Month 14.32% 94 / 100   
2 Months 315% 100 / 100   
6 Months 382% 100 / 100   
1 Year 742% 100 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog